−0.44 SEK
−1.81 M SEK
25.03 M SEK
About CORLINE BIOMEDICAL AB
Sector
Industry
CEO
Lars Henrik Nittmar
Website
Headquarters
Uppsala
Founded
1991
ISIN
SE0006887451
FIGI
BBG009BHZN38
Corline Biomedical AB engages in the business of developing a portfolio of drug candidates for use in connection with organ and cell transplantation. The firm is also involved in developing, manufacturing, and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the evolving field of regenerative medicine. The company was founded in 1991 and is headquartered in Uppsala, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CLBIO is 8.68 SEK — it has decreased by −0.23% in the past 24 hours. Watch CORLINE BIOMEDICAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CORLINE BIOMEDICAL AB stocks are traded under the ticker CLBIO.
CLBIO stock has risen by 5.08% compared to the previous week, the month change is a 33.54% rise, over the last year CORLINE BIOMEDICAL AB has showed a −38.44% decrease.
CLBIO reached its all-time high on Sep 28, 2018 with the price of 30.14 SEK, and its all-time low was 5.98 SEK and was reached on Nov 28, 2024. View more price dynamics on CLBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CLBIO stock is 4.07% volatile and has beta coefficient of −0.97. Track CORLINE BIOMEDICAL AB stock price on the chart and check out the list of the most volatile stocks — is CORLINE BIOMEDICAL AB there?
Today CORLINE BIOMEDICAL AB has the market capitalization of 212.58 M, it has increased by 7.05% over the last week.
Yes, you can track CORLINE BIOMEDICAL AB financials in yearly and quarterly reports right on TradingView.
CLBIO net income for the last quarter is −3.00 M SEK, while the quarter before that showed −4.37 M SEK of net income which accounts for 31.43% change. Track more CORLINE BIOMEDICAL AB financial stats to get the full picture.
No, CLBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORLINE BIOMEDICAL AB EBITDA is −8.99 M SEK, and current EBITDA margin is −1.45%. See more stats in CORLINE BIOMEDICAL AB financial statements.
Like other stocks, CLBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORLINE BIOMEDICAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CORLINE BIOMEDICAL AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CORLINE BIOMEDICAL AB stock shows the sell signal. See more of CORLINE BIOMEDICAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.